What is the address of CEJIPE-Médicale?

The registered office of CEJIPE-Médicale is located at Rue de Moresnet 29, 4720 Kelmis.

Is CEJIPE-Médicale still active?

Yes. According to the CBE (30 October 2026) CEJIPE-Médicale is active, legal situation “Normale toestand”, started on 10 January 2003.

Is CEJIPE-Médicale registered on Peppol?

No, CEJIPE-Médicale is currently not registered on the Peppol network.

What is the enterprise number of CEJIPE-Médicale?

The enterprise number of CEJIPE-Médicale is BE0479267102.

When was CEJIPE-Médicale founded?

CEJIPE-Médicale was founded on 10 January 2003.

Who are the directors of CEJIPE-Médicale?

According to the 2025 annual accounts, the directors of CEJIPE-Médicale are: Jean-Michel DECKERS.

Is CEJIPE-Médicale a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 January 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CEJIPE-Médicale make in 2025?

CEJIPE-Médicale posted a profit after taxes of € 173,810 in financial year 2025.

What is the revenue of CEJIPE-Médicale?

As a small company, CEJIPE-Médicale is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 266,600.

CEJIPE-Médicale (Private Limited) - Kelmis - BE0479267102

Dossier CEJIPE-Médicale, printed on 30 October 2026 from databakkes.be/en/0479267102/cejipe-medicale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

CEJIPE-Médicale from Kelmis, company number BE0479267102, closed financial year 2025 with a result of € 173,810 after tax. For that financial year CEJIPE-Médicale recorded a gross margin of € 266,600 and equity of € 784,251. Compared with financial year 2024, the result moved from € 126,181 to € 173,810. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 13, 2026.

What it is worth Healthy

€ 784,251

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 173,810

▲ 38% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 204,401

▼ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 327,636 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 30,365

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,550

▼ 83% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 260,869 Gross margin 2022: € 260,869 First fiscal year in the series	€ 263,528 Gross margin 2023: € 263,528 ▲ 1% vs 2022 (€ 260,869) Favourable step	€ 202,784 Gross margin 2024: € 202,784 ▼ 23% vs 2023 (€ 263,528) Unfavourable step	€ 266,600 Gross margin 2025: € 266,600 ▲ 31% vs 2024 (€ 202,784) Favourable step	▲ 31%
Profit after taxes	€ 169,079 Profit after taxes 2022: € 169,079 First fiscal year in the series	€ 167,506 Profit after taxes 2023: € 167,506 ▼ 1% vs 2022 (€ 169,079) Unfavourable step	€ 126,181 Profit after taxes 2024: € 126,181 ▼ 25% vs 2023 (€ 167,506) Unfavourable step	€ 173,810 Profit after taxes 2025: € 173,810 ▲ 38% vs 2024 (€ 126,181) Favourable step	▲ 38%
Equity	€ 974,026 Equity 2022: € 974,026 First fiscal year in the series	€ 1,141,532 Equity 2023: € 1,141,532 ▲ 17% vs 2022 (€ 974,026) Favourable step	€ 938,077 Equity 2024: € 938,077 ▼ 18% vs 2023 (€ 1,141,532) Unfavourable step	€ 784,251 Equity 2025: € 784,251 ▼ 16% vs 2024 (€ 938,077) Unfavourable step	▼ 16%
Total debts	€ 38,851 Total debts 2022: € 38,851 First fiscal year in the series	€ 52,922 Total debts 2023: € 52,922 ▲ 36% vs 2022 (€ 38,851) Unfavourable step	€ 356,664 Total debts 2024: € 356,664 ▲ € 303,742 vs 2023 (€ 52,922) Unfavourable step	€ 195,483 Total debts 2025: € 195,483 ▼ 45% vs 2024 (€ 356,664) Favourable step	▼ 45%
Cash	€ 405,255 Cash 2022: € 405,255 First fiscal year in the series	€ 534,043 Cash 2023: € 534,043 ▲ 32% vs 2022 (€ 405,255) Favourable step	€ 476,953 Cash 2024: € 476,953 ▼ 11% vs 2023 (€ 534,043) Unfavourable step	€ 204,401 Cash 2025: € 204,401 ▼ 57% vs 2024 (€ 476,953) Unfavourable step	▼ 57%
Land & buildings	€ 242,664 Land & buildings 2022: € 242,664 First fiscal year in the series	€ 223,843 Land & buildings 2023: € 223,843 ▼ 8% vs 2022 (€ 242,664) Unchanged	€ 205,834 Land & buildings 2024: € 205,834 ▼ 8% vs 2023 (€ 223,843) Unchanged	€ 197,759 Land & buildings 2025: € 197,759 ▼ 4% vs 2024 (€ 205,834) Unchanged	▼ 4%
Retained profit	€ 967,826 Retained profit 2022: € 967,826 First fiscal year in the series	€ 1,135,332 Retained profit 2023: € 1,135,332 ▲ 17% vs 2022 (€ 967,826) Favourable step	€ 931,877 Retained profit 2024: € 931,877 ▼ 18% vs 2023 (€ 1,135,332) Unfavourable step	€ 778,051 Retained profit 2025: € 778,051 ▼ 17% vs 2024 (€ 931,877) Unfavourable step	▼ 17%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 329,636 Dividend 2024: € 329,636 Unchanged (€ 0) Unchanged	€ 327,636 Dividend 2025: € 327,636 ▼ 1% vs 2024 (€ 329,636) Unchanged	▼ 1%
Balance sheet total	€ 1,012,878 Balance sheet total 2022: € 1,012,878 First fiscal year in the series	€ 1,194,455 Balance sheet total 2023: € 1,194,455 ▲ 18% vs 2022 (€ 1,012,878) Unchanged	€ 1,294,741 Balance sheet total 2024: € 1,294,741 ▲ 8% vs 2023 (€ 1,194,455) Unchanged	€ 979,734 Balance sheet total 2025: € 979,734 ▼ 24% vs 2024 (€ 1,294,741) Unchanged	▼ 24%

Key figures of CEJIPE-Médicale, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CEJIPE-Médicale?

What happened at CEJIPE-Médicale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 13, 2026 New annual accounts for financial year 2025: profit of € 173,810 (▲ 38% vs 2024). filed late Source: NBB ↗
Jan 10, 2003 Start of the company according to the CBE. KBO
Jan 1, 2003 New establishment in Kelmis. KBO

In short

From € 169,079 profit in 2022 to € 173,810 profit in 2025.

Paid € 280,204 in corporate taxes since 2022.

Best year ever: 2025, with € 173,810 profit.

Paid out € 657,273 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jean-Michel DECKERS

CEJIPE-Médicale

CENTRE MEDICAL POLYVALENT

Behind CEJIPE-Médicale is Jean-Michel DECKERS. Jean-Michel DECKERS is also behind CENTRE MEDICAL POLYVALENT.

Directors

According to the 2025 annual accounts

Jean-Michel DECKERS

Manager

Also active at: CENTRE MEDICAL POLYVALENT

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Moresnet 29

4720 Kelmis

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.267.102
VAT number: BE 0479.267.102
Registered office: Rue de Moresnet 29, 4720 Kelmis
Names & denominations: CEJIPE-Médicale
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 January 2003
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗